Immunome Inc.

NASDAQ: IMNM · Real-Time Price · USD
10.28
0.34 (3.42%)
At close: Aug 15, 2025, 1:54 PM

Immunome Revenue

Immunome reported an annual revenue of $9.04M, reflecting a -35.5% growth. For the quarter ending June 30, 2025, Immunome generated $4.01M in revenue.
Revenue (ttm)
9.04M
Revenue Growth
-35.5%
Price / Sales Ratio
68.88
Revenue / Employee
69.02K
Employees
131
Market Cap
894.82M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.